Kevin Choi, MD
Otolaryngology · Los Angeles, CANPI 1134486681
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Optinose US, Inc. at 45.1% of the total. Reporting peaked in 2020 at $3,411 and has fallen 63.9% since, to $1,232 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $101.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$4K
- Aerin Medical Inc.$1K
- Stryker$492
- Sanofi$470
- Medtronic$386
- Avanos Medical$226
- plus $1K from 14 others
Across 67 payments — averaging $4067.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$135K
- Neurent Medical Limited$84K
- Eli Lilly$22K
- Optinose US, Inc.$18K
- Sanofi US Services Inc.$13K
What the payments were for
- Speaking & faculty fees$3,25041%
- Travel & lodging$75810%
- Food & beverage$3,82749%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 15 | $3,531 |
| Aerin Medical Inc. | 8 | $1,384 |
| Stryker | 11 | $492 |
| Sanofi | 13 | $470 |
| Medtronic | 3 | $386 |
| Avanos Medical | 2 | $226 |
| Baxter Healthcare | 3 | $203 |
| GSK | 9 | $191 |
| Regeneron Healthcare Solutions, Inc. | 1 | $174 |
| SPR Therapeutics, Inc | 1 | $147 |
| Axogen | 2 | $134 |
| Olympus America Inc. | 1 | $127 |
| Aimmune Therapeutics, Inc. | 1 | $112 |
| Intuitive Surgical | 1 | $98 |
| Smith+Nephew | 1 | $39 |
| Intersect ENT, Inc. | 1 | $36 |
| AstraZeneca | 1 | $26 |
| Cochlear Americas | 1 | $22 |
| Neurent Medical Limited | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$3,175
- VIVAER STYLUS$1,262
- RHINAER STYLUS$1,262
- STEALTHSTATION S8 PLATFORM$285
- ON-Q* PUMP AND ACCESSORIES$226
- DUPIXENT$174
- SPRINT PNS System$147
- RHINO-LARYNGO VIDEOSCOPE$127
- ZENPEP$112
- PROPEL$101
How this compares
$7,834 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 526 | $13,310 |
| Ofloxacin | 215 | $12,407 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 140 | $12,187 |
| Azelastine Hcl | 547 | $7,701 |
| Mometasone Furoate | 122 | $3,929 |
| Dexamethasone | 94 | $2,920 |
| Famotidine | 402 | $2,522 |
| Fluticasone Propionate | 174 | $1,537 |
| Triamcinolone Acetonide | 462 | $1,402 |
| Pilocarpine Hcl | 20 | $696 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 65 | $428 |
| Doxycycline Hyclate | 54 | $428 |
| Desonide | 19 | $395 |
| Clotrimazole | 15 | $385 |
| Levothyroxine Sodium | 13 | $253 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Los Angeles
- Keith BlackwellLos Angeles$349K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Elisabeth FerenceLos Angeles$111K
- Arthur WuLos Angeles$67K
- Richard MichelinLos Angeles$57K
- Maie St JohnLos Angeles$39K
- Kevin GrafmillerLos Angeles$27K
- Philip KnottLos Angeles$24K
- Uttam SinhaLos Angeles$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.